Efficacy and safety of once-weekly semaglutide vs sitagliptin as add-on to metformin and/or thiazolidinediones after 56 weeks in subjects with Type 2 diabetes (SUSTAIN 2)

---

Ahren B., Comas L. M. , Kumar H., Sargin M., Karsbol J. D. , Jacobsen S. H. , ...More

DIABETIC MEDICINE, vol.34, pp.145, 2017 (Peer-Reviewed Journal)

• Publication Type: Article / Abstract
• Volume: 34
• Publication Date: 2017
• Journal Name: DIABETIC MEDICINE
• Journal Indexes: Science Citation Index Expanded, Scopus
• Page Numbers: pp.145